SEC Form 4 · accession 0000950138-17-000701
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melvin D Booth
Director
Period of report
Oct 1, 2017
Accepted (ET)
Oct 3, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Oct 1, 2017 | F | 476 | $37.37 | D | 8,477 | D | |
| Ordinary SharesF1 | holding | — | — | — | 23,279 | I | By Melvin D. Booth Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 3,898 shares previously owned directly which were contributed to the Melvin D. Booth Revocable Trust.
Remarks
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.